Company / Capital Returned to Shareholders per Share
ADMA Biologics, Inc. Capital Returned to Shareholders per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.13
FY2025
5-year range
$0.00 / $0.13
FY2023-FY2025
Trend
-
vs FY2024
Sector context
#40 of 51
Health Care
What the data says
ADMA Biologics, Inc.'s capital returned to shareholders per share of $0.13 is lower than 78% of companies in the Health Care sector (FY2025). Improved from $0.00 to $0.13 over the past 2 years.
Based on SEC 10-K filings.
0.13 in FY2025.
Improved from $0.00 to $0.13 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 51This company $0.13 Sector average $2.74
▼
-95.1% below sector average
Key checks
Key Insights
- Ranks #40 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026